220 related articles for article (PubMed ID: 34717147)
1. Inhibitory effects of sulforaphane on NLRP3 inflammasome activation.
Kiser C; Gonul CP; Olcum M; Genc S
Mol Immunol; 2021 Dec; 140():175-185. PubMed ID: 34717147
[TBL] [Abstract][Full Text] [Related]
2. Sulforaphane inhibits NLRP3 inflammasome activation in microglia through Nrf2-mediated miRNA alteration.
Tufekci KU; Ercan I; Isci KB; Olcum M; Tastan B; Gonul CP; Genc K; Genc S
Immunol Lett; 2021 May; 233():20-30. PubMed ID: 33711331
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane attenuates activation of NLRP3 and NLRC4 inflammasomes but not AIM2 inflammasome.
Lee J; Ahn H; Hong EJ; An BS; Jeung EB; Lee GS
Cell Immunol; 2016; 306-307():53-60. PubMed ID: 27423466
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of sulforaphane on diabetic retinopathy: activation of the Nrf2 pathway and inhibition of NLRP3 inflammasome formation.
Li S; Yang H; Chen X
Exp Anim; 2019 May; 68(2):221-231. PubMed ID: 30606939
[TBL] [Abstract][Full Text] [Related]
5. Sulforaphane decreases oxidative stress and inhibits NLRP3 inflammasome activation in a mouse model of ulcerative colitis.
Zhou ZJ; Dong JY; Qiu Y; Zhang GL; Wei K; He LH; Sun YN; Jiang HZ; Zhang SS; Guo XR; Wang JY; Chen DP
Biomed Pharmacother; 2024 Jun; 175():116706. PubMed ID: 38713944
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane improves outcomes and slows cerebral ischemic/reperfusion injury via inhibition of NLRP3 inflammasome activation in rats.
Yu C; He Q; Zheng J; Li LY; Hou YH; Song FZ
Int Immunopharmacol; 2017 Apr; 45():74-78. PubMed ID: 28189971
[TBL] [Abstract][Full Text] [Related]
7. Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation.
Yang G; Yeon SH; Lee HE; Kang HC; Cho YY; Lee HS; Lee JY
Rheumatology (Oxford); 2018 Apr; 57(4):727-736. PubMed ID: 29340626
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphane Protects Pancreatic Acinar Cell Injury by Modulating Nrf2-Mediated Oxidative Stress and NLRP3 Inflammatory Pathway.
Dong Z; Shang H; Chen YQ; Pan LL; Bhatia M; Sun J
Oxid Med Cell Longev; 2016; 2016():7864150. PubMed ID: 27847555
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane alleviates retinal ganglion cell death and inflammation by suppressing NLRP3 inflammasome activation in a rat model of retinal ischemia/reperfusion injury.
Gong Y; Cao X; Gong L; Li W
Int J Immunopathol Pharmacol; 2019; 33():2058738419861777. PubMed ID: 31266422
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane inhibits multiple inflammasomes through an Nrf2-independent mechanism.
Greaney AJ; Maier NK; Leppla SH; Moayeri M
J Leukoc Biol; 2016 Jan; 99(1):189-99. PubMed ID: 26269198
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphane reduces pro-inflammatory response to palmitic acid in monocytes and adipose tissue macrophages.
Williams EJ; Guilleminault L; Berthon BS; Eslick S; Wright T; Karihaloo C; Gately M; Baines KJ; Wood LG
J Nutr Biochem; 2022 Jun; 104():108978. PubMed ID: 35271969
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of phytochemicals on NLRP3 inflammasome activation: A review.
Olcum M; Tastan B; Ercan I; Eltutan IB; Genc S
Phytomedicine; 2020 Aug; 75():153238. PubMed ID: 32507349
[TBL] [Abstract][Full Text] [Related]
13. Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders.
Tastan B; Arioz BI; Genc S
Front Immunol; 2022; 13():865772. PubMed ID: 35418995
[TBL] [Abstract][Full Text] [Related]
14. A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet.
Yang G; Lee HE; Lee JY
Sci Rep; 2016 Apr; 6():24399. PubMed ID: 27075683
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
16. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
[TBL] [Abstract][Full Text] [Related]
17. Sulforaphane attenuates microglia-mediated neuronal damage by down-regulating the ROS/autophagy/NLRP3 signal axis in fibrillar Aβ-activated microglia.
Yang Y; Zhang J; Yang C; Dong B; Fu Y; Wang Y; Gong M; Liu T; Qiu P; Xie W; Lü T
Brain Res; 2023 Feb; 1801():148206. PubMed ID: 36539049
[TBL] [Abstract][Full Text] [Related]
18. Interplay Between NLRP3 Inflammasome and Autophagy.
Biasizzo M; Kopitar-Jerala N
Front Immunol; 2020; 11():591803. PubMed ID: 33163006
[TBL] [Abstract][Full Text] [Related]
19. URB597 protects against NLRP3 inflammasome activation by inhibiting autophagy dysfunction in a rat model of chronic cerebral hypoperfusion.
Su SH; Wu YF; Lin Q; Wang DP; Hai J
J Neuroinflammation; 2019 Dec; 16(1):260. PubMed ID: 31815636
[TBL] [Abstract][Full Text] [Related]
20. Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling.
Kim JK; Jin HS; Suh HW; Jo EK
Immunol Cell Biol; 2017 Aug; 95(7):584-592. PubMed ID: 28356568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
